UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
DC 20549
FORM
8-K
CURRENT
REPORT PURSUANT
TO
SECTION 13 OR 15(D) OF THE
SECURITIES
EXCHANGE ACT OF 1934
Date
of
report (Date of earliest event reported): October 30, 2006
SAFETEK
INTERNATIONAL, INC.
(Exact
name of Registrant as specified in its charter)
|
Delaware
(State
or other jurisdiction of incorporation)
|
33-22175
(Commission
File Number)
|
75-2226896
(IRS
Employer Identification No.)
|
23
Aminadav St.
Tel
Aviv, Israel, 67898
(Address
of principal executive offices)
972-3-561-3465
(Registrant's
Telephone Number, Including Area Code)
__________________________________________________
(Former
Name or Former Address, if Changed Since Last Report)
Check
the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below):
| o |
Written
communications pursuant to Rule 425 under the Securities Act (17
CFR
230.425)
|
| o |
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
| o |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR
240.14d-2(b))
|
| o |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR
240.13e-4(c))
|
Section
5 - Corporate Governance and Management
Item
5.02 Departure of Directors or Principal Officers; Election of Directors;
Appointment of Principal Officers.
On
October 28, 2006, the Board of Directors of Safetek International, Inc. (the
‘Registrant”) accepted the resignation of Tamar Tzaban Nahomov from her
positions as a director and Chief Financial officer of the Registrant and its
wholly owned subsidiary, Oriens Life Sciences (Israel) Ltd., effective as of
October 30, 2006.
Appointment
of Shmuel Shneibalg as a Director
On
October 28 2006, the Board appointed Shmuel Shneibalg as Chief Executive Officer
and as a director of the Registrant and its wholly owned subsidiary, effective
as of October 30, 2006, to serve until his successor is elected and qualified.
Mr.
Shneibalg has had considerable experience serving as a director and officer
of
several publicly traded companies. From May 2001 until April 2005, Mr. Shniebalg
served as Chairman, Chief Executive Officer, Secretary and Director of the
Registrant. He also served as Chief Executive Officer, Chief Financial Officer,
and President of Green Mountain Capital, Inc. from September 29, 2005 until
his
resignation on May 12, 2006 but he remains a director of the company. Mr.
Shneibalg has been a Vice-President and a Director of Global General
Technologies, Inc. since November 10, 2004 and the Vice President of Home
Solutions Health, Inc., a public consumer product company.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant
has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
| |
|
|
| |
SAFETEK
INTERNATIONAL, INC.
(Registrant)
|
|
|
|
| |
By: |
/s/
Shmuel Shneibalg |
| |
Name:
Shmuel
Shneibalg |
| |
Title:
Chief
Executive Officer and Director |
Date:
October 30, 2006